Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding

statement of authorship
T.Päll, A.Gad, L.Kasak, M.Drews, S.Strömblad, P.Kogerman
source
journal volume number month
23
year of publication
pages
47, p. 7874-7881
language
inglise
Päll, T., Gad, A., Kasak, L., Drews, M., Strömblad, S., Kogerman, P. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding // Oncogene (2004) 23, 47, p. 7874-7881. https://www.nature.com/articles/1208083